Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07357051
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients within the specified age range.
* Clinical presentation consistent with influenza, confirmed by a positive local rapid test or central laboratory PCR test.
* Presentation for treatment within the early symptomatic phase of influenza illness.
* Presence of fever and at least one respiratory symptom.
* Ability to swallow oral suspension.
* Parent/guardian and patient (as age-appropriate) able to provide informed consent/assent.
Exclusion Criteria:
* Clinical signs suggestive of severe or complicated influenza infection
* requiring inpatient management.
* Presence of a concurrent bacterial infection requiring systemic therapy.
* Significant immunocompromised, or severe/uncontrolled comorbid conditions.
* History of hypersensitivity to any component of the investigational products.
* Use of prohibited medications (including other anti-influenza antivirals) within a specified period prior to enrollment.
* Recent participation in another interventional clinical trial.
* Any condition that, in the opinion of the investigator, would jeopardize patient safety or compliance with the study protocol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
11 Years
Study:
NCT07357051
Study Brief:
Protocol Section:
NCT07357051